Sonova Holding AG (SIX:SOON) saw shares plummet as it cut its fiscal year guidance after releasing disappointing 2nd quarter earnings related to weak cochlear implant sales. Guidance for sales for the year dropped from 7-9% to 6-8% and earnings before interest, taxes and amoritisation were dropped significantly from 9-13% to 3-7%. Shares have dropped roughly […]
Otolaryngology/Ear, Nose & Throat (ENT)
C2 Therapeutics touts ColdPlay ablation system study data
C2 Therapeutics today released data from a study of its ColdPlay cryoballoon focal ablation system reporting no adverse events or complications with the device. The Redwood City, Calif.-based company’s device is designed to treat precursors to esophageal cancer known as Barrett’s esophagus. The Coldplay device uses extreme cold to destroy targeted diseased tissue while minimizing […]
Intersect ENT touts economic data from from Propel study
Intersect ENT (NSDQ:XENT) said today that budget impact data on its Propel steroid releasing implant for treating chronic sinusitis showed upfront costs offset by savings post-operatively. The data was presented at the International Society for Pharmaeconomics and Outcomes Research annual meeting in Milan, Italy. “A previous study demonstrated the use of Propel in sinus surgery […]
IntriCon acquires hearing aid company PC Werth
Intricon (NSDQ:IIN) said Tuesday it bought the assets ofhearing healthcare product manufacturer PC Werth, a leading hearing aid supplier to the U.K.’s National Health Service. Intricon said it inked an exclusive agreement with PC Werth last December to distribute its hearing aid products in the U.K., but the full acquisition will allow Intricon extra access […]
C2 Therapeutics Coldplay cryoballoon wins CE Mark
C2 Therapeutics said today its Coldplay cryoballoon focal ablation system won CE Mark approval in the European Union. The Redwood City, Calif.-based company’s device is designed to treat precursors to esophageal cancer known as Barrett’s Esophagus. The Coldplay device uses extreme cold to destroy targeted diseased tissue while minimizing damage to healthy tissue. “C2’s Coldplay […]
Intersect ENT files for expanded Propel PMA
Intersect ENT (NSDQ:XENT) said Tuesday it submitted a supplemental premarket approval application to the FDA to expand the indication on its Propel mini steroid releasing implant to cover frontal sinus surgeries. The new indication would allow the drug-device combo to be used in the frontal sinuses, located behind the eyebrows, the Menlo Park, Calif.-based company […]
EarLens wins FDA 510(k) for novel hearing aid
EarLens said Tuesday it won FDA 510(k) clearance for its laser diode-equipped direct vibration-based contact hearing device for use in adults with mild to severe sensorineural hearing impairment. The device is designed to directly contact the patient’s eardrum and use it as a speaker and act as an amplifier for a wide range of frequencies, […]
Smith & Nephew launch new dissolvable nasal splint
Smith & Nephew (NYSE:SNN) said yesterday it launched the Nasastent dissolvable structural intranasal splint designed to minimize bleeding and prevent post-op adhesions after sinus surgery. The implant is composed of plant-based caboxymethyl cellulose that provides support to hold the soft nasal tissue in place and pressure to prevent bleeding. The Nasastent eventually converts into a hydrocolloidal […]
Boston Scientific launches Captivator EMR device
Boston Scientific (NYSE:BSX) said today it launched the Captivator endoscopic mucosal resection device designed as a minimally-invasive alternative to esophagectomy procedures. The Captivator allows for staging and removal of precancerous tissue and early esophageal cancer in the upper gastrointestinal tract, the Marlborough, Mass.-based company said. The device gives operating physicians a 360 degree view of the esophagus and can […]
CEOs: The medtech investment climate is improving but getting tighter
By Scott Wooldridge The climate for investment in medical device companies is improving but getting tighter, as biotech and pharma horn in on the recovering economy, according to a pair of medtech CEOs speaking at last night’s DeviceTalks: Minnesota event. Entellus Medical (NSDQ:ENTL) CEO Bob White and Martha Shadan, president & CEO at Rotation Medical, spoke with LifeScience Alley CEO Shaye […]
Update: Aerin Medical raises $6.7m for nasal RF device
Nasal airflow device developer Aerin Medical raised $6.7 million in a new round of equity financing, according to an SEC filing posted last week, and CEO Fred Dinger spoke to MassDevice.com about the company’s trajectory and what the funding is slated for. Aerin Medical is developing a novel nasal breathing repair device for treating nasal […]